Managing Potential Side Effects of Arexvy
Arexvy, a brand-name injection developed by GSK, is designed to prevent lung disease caused by respiratory syncytial virus (RSV) in older adults. However, like any vaccine, it can come with side effects.
In clinical trials, common side effects of Arexvy have been reported, including injection site reactions, tiredness, muscle pain, and systemic symptoms like fever and fatigue. Mild side effects such as headache, fever, aching muscles or joints, and mild allergic reactions are also possible.
For those under 60 years of age, Arexvy is not approved. If you have any questions about alcohol use before or after getting the vaccine, it's best to discuss them with your doctor.
While serious side effects from Arexvy were rare in clinical trials, they can include a severe allergic reaction. For mild symptoms of an allergic reaction, call your doctor right away.
Other rare side effects not frequently reported in clinical trials but potentially occurring post-marketing include Guillain-Barré Syndrome (GBS), other rare neurological events, and rare systemic reactions. GBS is a serious condition characterized by muscle weakness and sometimes paralysis, requiring immediate medical attention.
Given that clinical trials might not capture all possible side effects, particularly rare ones, continued monitoring through post-marketing surveillance is crucial to identify any new or less common adverse events.
The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) track side effects of vaccines, including Arexvy, and can be notified through the Vaccine Adverse Event Reporting System (VAERS).
Most side effects caused by Arexvy are typically mild and should only last for a day or two after the injection. If you experience side effects that become more severe or do not go away, consult a doctor or pharmacist.
Your doctor may recommend over-the-counter pain medications such as acetaminophen (Tylenol) or ibuprofen (Advil) to relieve injection site reactions or aching muscles or joints.
It is unknown if Arexvy is safe during pregnancy or while breastfeeding. If you'd like to learn more about Arexvy, talk with your doctor or pharmacist.
Arexvy is administered as an injection into the deltoid muscle on the upper arm. Aching muscles or joints were a common side effect in clinical trials of Arexvy, typically in the arm where the injection was given. These side effects may be temporary, lasting a few days to weeks, but if they last longer or become severe, consult a doctor or pharmacist.
The side effects reported with Arexvy and Abrysvo in older adults were similar, including injection site pain, fatigue, headache, and muscle pain.
- The immunizations (vaccines) like Arexvy, developed to prevent lung disease caused by respiratory syncytial virus (RSV), can have side effects, such as injection site reactions, tiredness, muscle pain, fever, fatigue, headache, fever, aching muscles or joints, and mild allergic reactions.
- For those aged below 60, Arexvy is not approved, and questions about alcohol use before or after getting the vaccine should be discussed with a doctor.
- While serious side effects from Arexvy were rare in clinical trials, they include a severe allergic reaction, Guillain-Barré Syndrome (GBS), other rare neurological events, and rare systemic reactions.
- In order to identify any new or less common adverse events, continued monitoring through post-marketing surveillance is essential, with the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) tracking side effects of vaccines like Arexvy.
- If experiencing side effects from Arexvy that become more severe or do not go away, it is advisable to consult a doctor or pharmacist, and over-the-counter pain medications such as acetaminophen (Tylenol) or ibuprofen (Advil) may be recommended to relieve injection site reactions or aching muscles or joints.
